Support for clinical trials
Through the Support for Cancer Clinical Trials and Boost Cancer Research programs, the Australian Government provides $10 million per annum to build Australia’s capacity to undertake cancer clinical trials and support industry-independent cancer clinical trial research in cancer treatment and care.
Clinical trials are fundamental to establishing whether new cancer treatments or new ways of using existing therapies, diagnostic tests, preventative or supportive interventions are effective and they help generate the evidence for best-practice cancer care.
The Support for Cancer Clinical Trials program provides funding to Australia's Multi-site, Collaborative National Cancer Clinical Trials Groups to build their capacity to undertake cancer clinical trials and the Boost Cancer Research measure provides support to establish additional new Multi-site Collaborative National Cancer Clinical Trials Groups, extend the conduct of cooperative clinical trials into regional and rural areas, and provides research grants to undertake cancer clinical trial research in identified priority areas.
Cancer Australia supports cancer clinical trials in Australia in the following ways:
- Supports the Multi-site Collaborative National Cancer Clinical Trials Groups to build their capacity to conduct clinical trials
- Funds the provision of centralised services to assist the Multi-site, Collaborative National Cancer Clinical Trials Groups through:
National Secretariat Services
Cancer Australia Chair in Cancer Quality of Life
Cancer Clinical Trials Development Unit
Cancer Australia is also undertaking specific work on increasing clinical trial information available to consumers.
Newsletter Subscription
